Doximity (NYSE:DOCS) Stock: Insider Siddharth Sitaram Sells 2,613 Shares

Doximity, Inc. (NYSE:DOCS) CAO Siddharth Sitaram sold 2,613 shares of the stock in a transaction dated Wednesday, October 14th. The shares were sold at an average price of $30.68, for a total transaction of $80,166.84. Following the completion of the sale, the chief accounting officer owned 101,432 shares of the company’s stock, valued at approximately $3,111,933.76. The trade was a 2.51% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Siddharth Sitaram also recently made the following trade(s):

• On Tuesday, September 15th, Siddharth Sitaram sold 2,077 shares of Doximity stock. The stock was sold at an average price of $26.02, for a total value of $54,043.54.
• On Thursday, August 13th, Siddharth Sitaram sold 1,770 shares of Doximity stock. The shares were sold at an average price of $24.94, for a total value of $44,143.80.

Doximity Stock Down 2.2%

Doximity stock opened at $30.81 on Friday. The business has a 50 day moving average price of $26.75 and a two-hundred day moving average price of $23.63. The stock has a market cap of $5.49 billion, a price-to-earnings ratio of 36.25, a price-to-earnings-growth ratio of 24.22 and a beta of 1.22. Doximity, Inc. has a 12 month low of $17.15 and a 12 month high of $71.37.

Doximity (NYSE:DOCS) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.13. Doximity had a return on equity of 18.06% and a net margin of 25.48%. The company had revenue of $156.62 million for the quarter. During the same period in the previous year, the business posted $0.36 EPS. Doximity’s revenue for the quarter was up 7.3% compared to the same quarter last year. On average, analysts expect that Doximity, Inc. will post 0.74 earnings per share for the current fiscal year.

Doximity News Summary

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity extended its 13-year alliance with U.S. News, supporting physician searches, appointment booking and hospital rankings. The partnership could reinforce user engagement and patient-access offerings. Doximity Deepens U.S. News Alliance to Improve Patient Access to Care
• Neutral Sentiment: Doximity will release fiscal 2027 second-quarter results on November 5, giving investors the next major opportunity to assess growth, advertising trends and management’s outlook. Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026
• Negative Sentiment: Several law firms publicized a securities-fraud class action against Doximity and certain individuals, including co-founder and former Chief Strategy Officer Nate Gross. The allegations reportedly concern statements that Doximity could gain market share while older advertising formats were losing ground to programmatic and social-media competitors; the claims have not been established in court.
• Negative Sentiment: Investors who purchased DOCS shares between August 8, 2024 and May 13, 2026 are being reminded that November 16, 2026 is the deadline to seek appointment as lead plaintiff. Repeated announcements from Robbins Geller, SBS Law, Kaplan Fox, Rosen, Pomerantz, Bronstein Gewirtz Grossman and other firms increase the visibility of the legal overhang and could weigh on sentiment. DOCS Investor Alert

Analyst Ratings Changes

Several research analysts recently commented on the company. Piper Sandler reaffirmed an “overweight” rating and issued a $47.00 target price (up from $42.00) on shares of Doximity in a research report on Friday, August 7th. Citigroup lowered shares of Doximity to an “underperform” rating in a report on Monday, June 29th. Needham & Company LLC reissued a “buy” rating and issued a $41.00 price target on shares of Doximity in a report on Friday, August 7th. JPMorgan Chase & Co. increased their price objective on shares of Doximity from $26.00 to $31.00 and gave the company a “neutral” rating in a research note on Friday, August 7th. Finally, Truist Financial increased their price objective on shares of Doximity from $19.00 to $24.00 and gave the company a “hold” rating in a research note on Thursday, August 13th. Eight research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $30.73.

Institutional Investors Weigh In On Doximity

Institutional investors have recently added to or reduced their stakes in the stock. Assenagon Asset Management S.A. acquired a new position in shares of Doximity in the 3rd quarter worth approximately $28,858,000. Fortitude Family Office LLC lifted its position in shares of Doximity by 31,271.4% during the 3rd quarter. Fortitude Family Office LLC now owns 2,196 shares of the company’s stock worth $62,000 after buying an additional 2,189 shares during the period. Krilogy Financial LLC bought a new position in shares of Doximity during the 3rd quarter worth approximately $220,000. Sax Wealth Advisors LLC acquired a new stake in Doximity in the 3rd quarter valued at $205,000. Finally, GAMMA Investing LLC boosted its stake in Doximity by 19.8% in the 3rd quarter. GAMMA Investing LLC now owns 5,834 shares of the company’s stock valued at $165,000 after buying an additional 963 shares in the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Company Profile

Doximity, Inc operates a digital platform designed for U.S. medical professionals. Its network enables physicians, nurse practitioners, physician assistants and other healthcare providers to connect with colleagues, exchange clinical information and access professional resources.

The company offers tools for telehealth and care coordination, including video and phone-based communication services, as well as digital faxing and secure messaging capabilities. Doximity also provides medical news and research content tailored to healthcare professionals.

Doximity generates additional business through recruiting and marketing solutions that help healthcare organizations reach clinicians and promote employment opportunities, services and products.